Apeiron Biologics

About:

Apeiron Biologics is a biotech company that focuses on the discovery and development of novel cancer immunotherapies.

Website: https://www.apeiron-biologics.com/

Twitter/X: apeironbio

Top Investors: European Investment Bank, Die Vienna Insurance Group

Description:

APEIRON is a focused on the discovery and development of novel cancer immunotherapies. APEIRON’s lead clinical program APN401 is a first-in-class autologous cellular therapy to enhanc immune reactivity via an intracellular immune master checkpoint, Cbl-b. APEIRON’s key projects and technologies are bolstered by a strong patent portfolio with broad territorial coverage. APEIRON’s development expertise is validated through partnerships with leading global pharmaceutical companies and academic institutions.